Normal Balloon Catheter Market

Normal Balloon Catheter Market Outlook (2023 to 2033)

The global normal balloon catheter market is valued at US$ 2.21 billion in 2023. Fact.MR states that worldwide sales of normal balloon catheters are projected to increase at a CAGR of 7% during the next 10 years and reach US$ 4.35 billion by 2033-end.

A normal balloon catheter, also known as a standard balloon catheter, is typically a cardiology device used in medical procedures, particularly in interventional cardiology and vascular operations. It consists of a long, thin, flexible tube called a catheter with an inflatable balloon at its tip. Normal balloon catheter is used during the angioplasty procedure to widen narrowed or blocked blood vessels.

Based on the specific disease, there are several catheters available such as cutting balloon catheters, angioplasty balloon catheters, coronary balloon catheters, peripheral balloon catheters, vascular balloon catheters, guidewire balloon catheters, stent graft balloon catheters, drug-eluting balloon catheters, bioresorbable balloon catheters, urinary catheters, and scoring balloon catheters.

Rising number of interventional cardiology procedures across the world is primarily driving the utilization of normal balloon catheters. Also, rising cases of patients affected with end-stage renal disease are driving the demand for central venous catheters.

Growing awareness about renal disease is increasing the number of patients seeking renal replacement therapy. Leading manufacturers of catheter devices are developing efficient and cost-effective normal balloon catheter systems. These incidences are further influencing the growth of the global normal balloon catheter market.

Increasing geriatric population and rising investments in research & development activities concerning normal balloon catheters are expected to boost the demand for balloon catheters during the next 10 years. Also, the increasing use of balloon catheters for coronary artery disease and the growing demand for normal balloon catheters in cardiac catheterization laboratories are expected to boost the production of normal balloon catheters during the study period.

• Worldwide sales of nylon normal balloon catheters are forecasted to rise at a CAGR of 6% from 2023 to 2033.

Polyurethane and nylon are two material types of normal balloon catheters. Nylon normal balloon catheters are currently holding a dominating share in the global market. This is mostly due to the advantages of using nylon as a raw material in these devices, nylon is softer and easier to refold and withdraw into the guiding catheter or introducer sheath.

When compared to polyurethane normal balloon catheters, nylon high-pressure balloons require a thicker wall to withstand a specified burst pressure. This suggests that within the context of insertion into the body and navigating through a lesion, there is a higher use of nylon normal balloon catheters as compared to polyurethane balloon catheters.

Report Attributes	Details
Normal Balloon Catheter Market Size (2023E)	US$ 2.21 Billion
Forecasted Market Value (2033F)	US$ 4.35 Billion
Global Market Growth Rate (2023 to 2033)	7% CAGR
Market Share of Top 5 Normal Balloon Catheter Manufacturers	40%
Key Companies Profiled	Abbott Laboratories Boston Scientific Corporation Medtronic plc Terumo Corporation MicroPort Scientific Corporation B. Braun Melsungen AG Meril Life Sciences Pvt. Ltd. Hexacath Tokai Medical Products Inc. Cook Medical INC Cordis Corporation Biotronik SE & Co. KG.

Why Have Normal Balloon Catheters Gained Widespread Popularity?

“Angioplasty Balloon Catheters Effective for Cardiovascular Surgeries”

Rising prevalence of cardiovascular diseases is subsequently increasing the number of cardiology intervention procedures worldwide. Several respective governments across the globe are offering reimbursement support to their citizens who are living with vascular diseases. These factors are positively influencing the demand for angioplasty catheters.

Introduction of advanced balloon catheters and augmented research funding directed toward the development of multi-functional balloon catheters are expected to be key drivers of the balloon catheter market.

• According to the World Health Organization, heart disease stands as the foremost cause of global mortality, claiming approximately 17.9 million lives per year. Notably, heart attacks and strokes together account for four out of every five deaths due to heart disease.
• According to the same source, one-third of these fatalities occur in individuals under the age of 70.

Factors such as hypertension, elevated cholesterol levels, and hyperglycemia are placing individuals in a high-risk category for heart disease. Furthermore, these factors are anticipated to contribute to the high sales of cardiovascular catheters during the next 10 years.

“Balloon Catheter Innovations Minimizing Patient Discomfort and Increasing Operational Efficiency”

Innovations in materials and designs are increasing the capabilities of normal balloon catheters. The use of advanced materials such as nylon is increasing the flexibility of balloon catheters. Improved flexibility aids in easier navigation through intricate vascular structures, enhancing the precision of procedures. This not only minimizes patient discomfort during insertion but also enables access to narrower and more challenging vessels.

Innovations in catheter coatings and materials are also enhancing the visibility under fluoroscopy and other imaging techniques, which allows physicians to precisely position the catheter during procedures.

One of the most notable advancements in the field of balloon catheters is the development of multi-functional catheters. These catheters have the capability to address various cardiac issues within a single procedure. This not only saves time but also reduces the risks associated with multiple interventions. Combining multiple functions into a single catheter can result in cost savings for healthcare providers and patients, as it helps in reducing the need for additional devices and procedures.

Multi-functional catheters are expanding treatment possibilities and making it possible to address a wider range of cardiac conditions. Thus, the development of advanced balloon catheters and the advent of multi-functional are significantly driving the normal balloon catheter market growth.

What’s Hindering Revenue Growth of Normal Balloon Catheter Suppliers?

“Catheter-based Surgeries Not Budget-friendly for Low-income Patients”

The cost of balloon catheter procedures is a critical factor that can significantly influence patient decisions. In regions with limited insurance coverage or low economy, patients may be required to pay a substantial portion of the surgical costs. This is significantly hesitating patients with low budgets to undergo catheter-based procedures

Balloon catheter procedures may not only involve the cost of the procedure itself but also expenses related to post-operative care and medications. All these aspects distract patients from options related to catheter interventional procedures, subsequently hampering sales of normal balloon catheter equipment.

“Reputation of Companies Being Dented by Faulty Catheter Recalls”

Recalls or safety issues associated with balloon catheters can hamper the reputation of manufacturers and their products. This can lead to a loss of trust in the market as patients and healthcare providers may become cautious about the safety and reliability of these devices.

Recalls can also trigger regulatory agencies' attention, which can result in high scrutiny. Regulatory authorities may revise and tighten the safety standards and approval processes, which may further delay the entrance of new products.

Is the Normal Balloon Catheter Market a Profitable Space for Start-ups to Enter?

“Innovative Product Development to Aid New Manufacturers in Making a Mark”

New companies should invest in research and development activities to create innovative balloon catheter designs with unique features that address specific clinical needs or offer advantages over existing catheters. Innovation can increase market reach and aid in earning high shares.

Collaborations with established healthcare institutions and key market leaders can aid newcomers to gain key insights related to catheters and be a part of new trials. This move is expected to increase their distribution networks and gain trust among end users.

• Founded in 2016 in South Korea, Gmeditec is the pioneering company behind the innovation of a 3D surgical navigation device and the fusion method for balloon catheters.

Country-wise Analysis

As per this analysis by Fact.MR, a market research and competitive intelligence provider, growing trend towards minimally invasive procedures, including angioplasty and stent placement, is driving the demand for normal balloon catheters in North America. Also, economic development, urbanization, and developments in healthcare infrastructure are expected to increase the adoption of normal balloon catheters in Latin America during the next 10 years.

Why is the United States a Profitable Market for Normal Balloon Catheter Producers?

“Presence of Advanced Healthcare Facilities and Key Market Players Pioneering Catheter Developments”

Normal balloon catheter demand in the United States is experiencing robust growth. This growth can be attributed to several key factors, including the presence of advanced healthcare facilities and infrastructure, the strong spending power of individuals for healthcare services, and a high level of health awareness among patients.

Presence of several prominent companies such as Boston Scientific, Medtronic, and Abbott Laboratories in the United States is driving the normal balloon catheter sales growth. These companies are continuously investing in research and development activities to introduce innovative catheter devices.

How is Demand for Normal Balloon Catheter Evolving in Germany?

“Beneficial Healthcare Reimbursement Policies Aiding Catheter Sales Growth”

German medical device manufacturers are known for their focus on innovation. They are at the forefront of introducing catheters with advanced materials and coatings to enhance performance and reduce complications.

The country's robust healthcare system with reimbursement policies for medical procedures is encouraging patients to opt for treatments involving normal balloon catheters.

What’s Influencing the Sales of Balloon Catheters in Japan?

“Designing of Advanced Catheters for Effective Treatment of Senior Patients”

Japan's ageing demographic is contributing to the high demand for cardiovascular treatments. Balloon catheter procedures are the leading treatment options for conditions such as coronary artery disease and peripheral artery disease.

Japanese catheter companies are investing heavily in research and development initiatives to produce innovative catheter technologies. Their focus is on creating catheters that cater to the specific needs of the ageing population.

Category-wise Analysis

Hospitals and clinics both serve effective roles in catheterization procedures. Hospitals are the primary facilities for performing complex cardiovascular procedures using normal balloon catheters, especially in emergency cases due to the presence of advanced infrastructure.

Will Hospitals Continue to Be Prime Users of Normal Balloon Catheters?

“Advanced Medical Devices and Professionals Available at Hospitals”

Use of normal balloon catheters in hospitals is increasing at a rapid pace. Hospitals are the major users of normal balloon catheters because of the high intake of target patients due to the availability of advanced medical equipment and skilled healthcare professionals.

Growing cases of chronic diseases and rising demand for efficient and effective surgical procedures with shorter recovery times are driving demand for balloon catheters in hospitals.

Competitive Landscape

Several normal balloon catheter manufacturing companies are implementing merger and acquisition plans to differentiate them as prominent competitors in the market and to increase their sales.

PTA balloon manufacturing companies are forming alliances to improve their product portfolios and extend their worldwide footprints. The introduction of new products is another method used by manufacturers of normal balloon catheters to increase their market share and domination.

• In 2021, Medtronic plc expanded its product folio by introducing a new catheter variant - a balloon catheter designed to release medications precisely at the point of administration.

Key Segments of Normal Balloon Catheter Industry Research

• By Raw Material :

  • Polyurethane
  • Nylon

• By Indication :

  • Coronary Artery Disease
  • Peripheral Vascular Disease
  • Preventing Blood Vessel Constriction
  • Percutaneous Coronary Intervention

• By End User :

  • Hospitals
  • Ambulatory Surgical Centers
  • Cardiac Catheterization Laboratories

• By Region :

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia & Oceania
  • MEA